UK markets closed

Silence Therapeutics plc (SLNCF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.90990.0000 (0.00%)
At close: 02:27PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 105.56M
Enterprise value 31.68M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.79
Price/book (mrq)4.16
Enterprise value/revenue 1.13
Enterprise value/EBITDA -0.64

Trading information

Stock price history

Beta (5Y monthly) 0.62
52-week change 3-72.00%
S&P500 52-week change 314.90%
52-week high 33.2500
52-week low 30.6000
50-day moving average 30.7890
200-day moving average 31.5011

Share statistics

Avg vol (3-month) 3160
Avg vol (10-day) 3N/A
Shares outstanding 5116.01M
Implied shares outstanding 6110.24M
Float 844.6M
% held by insiders 144.37%
% held by institutions 140.25%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in GBP.

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Sept 2023


Profit margin -151.99%
Operating margin (ttm)-453.86%

Management effectiveness

Return on assets (ttm)-26.62%
Return on equity (ttm)-157.47%

Income statement

Revenue (ttm)28.04M
Revenue per share (ttm)0.77
Quarterly revenue growth (yoy)-17.00%
Gross profit (ttm)6.62M
EBITDA -46.92M
Net income avi to common (ttm)-42.62M
Diluted EPS (ttm)-0.5000
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)58.81M
Total cash per share (mrq)0.51
Total debt (mrq)315k
Total debt/equity (mrq)1.58%
Current ratio (mrq)4.86
Book value per share (mrq)0.52

Cash flow statement

Operating cash flow (ttm)-40.89M
Levered free cash flow (ttm)-29.14M